Cardiac resynchronization using fusion promotion for timing management
US10870008B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2017 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Oct 21, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/37512
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker and an extracardiac device. The extracardiac device is configured to analyze one or more QRS complexes of the patient's heart, determine whether fusion pacing is taking place, and, if not, to communicate with the leadless cardiac pacemaker to adjust intervals used in the CRT in order to generate desirable fusion of the pace and intrinsic signals. The extracardiac device may take the form of a subcutaneous implantable monitor, a subcutaneous implantable defibrillator, or other devices including wearable devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.